leisure time -WSS

leisure time

author：knowledge 2025-09-29 16:21:15 - browse：716

Cambridge: AbbVie — Ruby Wallau for STAT

AbbVie will pay $10 billion for the biotech firm Immunogen, the company said Thursday, acquiring an approved treatment for ovarian cancer and buying into a burgeoning area of oncology.

Under the agreement, AbbVie will pay $31.26 per share in cash for Immunogen, a nearly 100% premium to the company’s recent trading price. Central to the deal, expected to close in the middle of next year, is Elahere, an Immunogen product that won Food and Drug Administration approval for advanced ovarian cancer in 2022.

Elahere is among a surging class of cancer medicines called antibody-drug conjugates, or ADCs, which are designed to deliver a targeted dose of chemotherapy directly to tumor cells while sparing healthy tissues. AbbVie’s acquisition is the latest multibillion-dollar deal in the space, following Merck’s $22 billion agreement with ADC specialist Daiichi Sankyo and Pfizer’s $43 billion buyout of Seagen earlier this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Readout Newsletter: BridgeBio, Akero, and human embryo models

leisure time

WSS

Artificial intelligence advances fuel industry trying to preserve loved ones after death

The untold story of TV’s first prescription drug ad

Review: 'Barbie' will hit you like a shot in the heart

The untold story of TV’s first prescription drug ad

In new study, freeze

In new study, freeze

knowledge

leisure time

hotspot

How one medical school became remarkably diverse

He's 19 months old and has one of the world’s rarest diseases

After affirmative action ruling, medical educators look to 'holistic review'

7 of the most gruesome medical devices in history

Medicare proposal to cover medical devices draws a mixed reaction

Medicare drug price negotiation continues, as pharma counteroffers

Moonlake's readout produced a cash windfall. Risks remain

Ozempic has benefits for kidney disease as well as diabetes

In Memoriam: Notable people who died in 2023

Stem cell biologist probes earliest stages of human development

Wikipedia

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Stem cell biologist probes earliest stages of human development

In new study, freeze

Ozempic has benefits for kidney disease as well as diabetes

How artificial intelligence is being used to detect, treat cancer

focus

hotspot

leisure time

entertainment